• The first electrochemical immunosensor for monitoring CIP2A, a salivary oncoprotein.
Introduction
Oral cancers (OCs) are the thirteenth most common cancers in the world with approximately 300,000 new cases and 145,000 deaths annually(M. Merzianu, 2017) . Despite occurring in one of the most accessible anatomical sites of the human body, early diagnosis of OC is challenging as 70% of oral malignancies are diagnosed in advanced stages (Sankaranarayanan et al., 2010) .
Hence, the prognosis of OC patients is generally poor as the overall 5-year survival rate for OCs is less than 40% (Lingen et al., 2008) . In an effort to improve prognosis, a wide variety of OC screening techniques have been developed including visual screening (Lingen et al., 2008) , toluidine blue (TB) staining (Patton et al., 2008) , auto-fluorescence spectroscopy (Richards-kortum and Sevick-muraca, 1996) , exfoliative cytology (Lingen et al., 2008) , and biopsy/histopathology (M. Merzianu, 2017) . However, these techniques suffer from issues such as low sensitivity, lack of specificity for malignant tissue, and are also time-consuming, expensive, and labor intensive (M. Merzianu, 2017) .
Electrochemical-based biosensors comprised of interdigitated electrodes (IDEs) and monitored with electrochemical impedance spectroscopy (EIS) may hold the key to point-of-care cancer diagnostics (Chikkaveeraiah et al., 2012; Medina-Sánchez et al., 2016; Yang et al., 2004) .
IDEs consist of alternating 'finger-like' electrodes that are electrically connected with a width and pitch typically in the range of 5 -25 µm (Fowler et al., 2009; Xiuting Li et al., 2017) . IDEs inherently operate well as electrochemical transducers as they exhibit low ohmic drops, large collection efficiencies, high signal-to-noise ratios, and fast response times (Bratov et al., 2008; Kokkinos et al., 2016; Varshney et al., 2007; Yang et al., 2004) . EIS is often employed as the sensing modality for IDE-based immunosensors due to its ability to detect small variations in resistance/capacitance which offers the potential for label-free, real-time, and in situ detection of various analytes (Bratov et al., 2008) . Moreover, electrochemical IDEs have recently shown tremendous promise in detecting cancer linked proteins with low detection limits and wide sensing ranges [e.g., 0.1 ng/mL to 1000 ng/mL for carcinoembryonic antigen (CEA) (Xueqin Li et al., 2017 ), 0.01 to 100 ng/mL for human immunoglobulin A (IgA) (Ohno et al., 2013) , and 1.0 pg/L to 1.0 µg/L for prostate specific antigen (Huang et al., 2009)] . Although these reported IDE-based immunosensors circumvent much of the laboratory expertise and time associated with conventional immunoassay-based tests (Lequin, 2005) , they typically require the use of a secondary Ab label conjugated with either a conductive nanoparticle or enzyme-nanoparticle bioconjugate. Such labeling techniques are utilized to amplify the heterogeneous charge transport at the sensor-liquid interface, because of the relatively insulating qualities of the biorecognition agents themselves and/or the surface functionalization motifs (Bogomolova et al., 2009; Jonathan C. Claussen et al., 2011; Pei et al., 2001) . Consequently, such labeling requirements increase the complexity of the biosensing protocol and diminish the likelihood of point-of-care (POC) testing.
Herein we report, the first EIS IDE immunosensor for a biomarker related to oral cancer, viz., CIP2A, as well as to malignancies such as breast cancer and multiple myeloma (Katz et al., 2010a; Paluszczak et al., 2015) . The oncoprotein CIP2A promotes malignant cell growth and tumor progression and is generally overexpressed in most human cancers including lung, breast and gastric cancers (Haesen et al.,2012; Junttila et al.,2007; Kast et al., 2015; Khanna et al., 2009; Côme et al., 2009; Don et al.,2011) However, CIP2A expression is more pronounced in oral cancers as compared to lung and gastric cancers with 85% of tongue cancer specimens (Katz et al., 2010b) and 90% of esophageal squamous cell carcinoma the specimens (Qu et al., 2010) . scoring moderately or strongly positive. Moreover, CIP2A is abundantly expressed in oral squamous cell carcinoma lines as well as dysplastic and malignant human oral epithelial tissues Basile et al., 2017; Yu et al., 2014) . Therefore, the developed CIP2A biosensor could be of significant value towards the development of an oral cancer screening test.
The immunosensor developed in this work is the first to use 3D high-aspect-ratio vertically aligned carbon nanotube arrays (VANTAs) arranged in a 2D IDE footprint to enable rapid, labelfree CIP2A monitoring. The high surface area of the VANTA IDEs and favorable materials properties of carbon nanotubes (CNTs) (e.g., high electrical conductivity, electrochemical reactivity, and biocompatibility) (Claussen et al., 2009; Wang, 2005; Wang and Musameh, 2003) leads to a higher biosensor sensitivity than a comparable ELISA test kit. Moreover, the IDE designs requires facile lithographic patterning to create the CNT seed catalyst metal within a micro IDE pattern. Such patterning requires significantly reduced cleanroom processing than other immunosensors such as field effect transistors (FETs) that require nano/microwire gate development, gate oxide growth, deposition of active source/drain regions, reference electrode deposition, and passivation layer formation (Ding et al., 2017; de Vasconcelos et al., 2009 ).
Furthermore, cracks in the passivation layer of FETs can significantly alter biosensor outputs leading to false positive/negative signals. The use of IDEs in conjunction with an electrochemical sensing modality also eliminates the need for target analyte labeling with fluorophores or Förster resonance energy transfer (FRET) dye pairs that are difficult to characterize and highly variable with in-field biological and/or turbid samples (Ding et al., 2015; Downing et al., 2012; Piston and Kremers, 2007) as well as the need for pre-enrichment steps that require upwards of 24-48 hours before biosensor signal acquisition as is the case with many lateral flow assayed immunosensors (Brodsky et al., 2011; Piston and Kremers, 2007; Poltronieri et al., 2014) . Moreover, electrochemical sensing yields a qualitative signal that can report a specific target analyte concentration as opposed to many colorimetric biosensors that report only qualitative results (Grieshaber et al., 2008; Lee et al., 2010) . Hence, the developed CIP2A biosensors are highly conducive to in-field POC diagnostics.
Results and discussion

Fabrication and electrochemical characterization of VANTA IDE
The VANTA IDEs were developed on silicon/silicon oxide wafers coated with an aluminum oxide (Al2O3) layer (Figure 1 & Supplemental Information) . Briefly, a thin (~ 7 nm) iron catalytic layer was patterned in an IDE arrangement (10 fingers per electrode with each finger measuring 1.95 mm in length and 25 µm width and spacing) with two electrical probe pads on the wafer using physical vapor deposition (PVD) and ultraviolet (UV) photolithography (Figure 1b & 1c) . The high-aspect-ratio VANTAs were subsequently grown on the IDE patterned iron layer using a chemical vapor deposition (CVD) method followed by an amorphous carbon infiltration process for structural support according to our previous work (Figure 1d ) (Brownlee et al., 2017; . The VANTA IDEs exhibited a height to width ratio of approximately 3 to 1 as the CNT height measured approximately 75 µm. After IDE fabrication, anti-CIP2A Ab was attached to the surface and used to capture CIP2A antigen (Ag) (Figure 1e and materials and methods section in supplemental section). Prior to electrochemical sensing tests in the active solution, the electrical resistances of the two finger combs of the VANTA IDE were measured with 10-20 W resistance across a contact pad (corner to corner). The VANTA IDEs were next treated with O2 plasma to remove the carbon floor between the fingers of the IDE created from the amorphous carbon deposition process (see Methods and Materials section). After this O2 plasma etch, an infinitely high resistance between the two distinct finger combs was observed (i.e. no electrical shorting across the IDE fingers). This O2 plasma treatment also enhances the surface wettability of the CNTs so that the static contact angle changes from ~110 º (hydrophobic; see to ~69 º (hydrophilic; see Fig. S3 in Supplemental Information). Such an oxygenated, hydrophilic surface improves the penetration of aqueous solutions into the porous VANTA structure and consequently enhances the biofunctionalization and biosensor sensitivity (Marr et al., 2015, Banks and Compton, 2006; Claussen et al., 2012) . The general dimensions of VANTA IDEs are shown in Figure 1f , while the highly porous and defect-rich nature of the VANTA structures was observed with field-effect scanning electron microscopy (FESEM) (Figure 1g, 1h) . The high resolution FESEM images revealed individual nanotubes as well as the carbon matrix binding along the sidewall of the VANTAs. The entanglement of amorphous carbon and VANTAs resulted in mechanically stable structures during subsequent biofunctionalization and electrochemical sensing. Raman spectra revealed a G-band (~1590 cm -1 ), and 2D-band (~2700 cm -1 ), which correlates well with the spectra commonly associated with CNTs ( Figure 1i and materials and methods section in supplemental section). Moreover, the presence of the D-band (~1350 cm -1 ) and its high intensity relative to the G-peak intensity (ID/IG~0.94) indicates a high quantity of superficial carbon defects (Mu et al., 2006; S.Costa et al., 2008) . Such carbon defects are indicative of edge plane sites that have been shown to increase heterogeneous charge transfer during electrochemical sensing and deposition (Banks and Compton, 2006; Claussen et al., 2012) . 
where n is the number of electrons transferred by the Fe 3+ /Fe 2+ redox couple (n=1), v is the scan rate (v =100 mV/s), D is the diffusion coefficient (D = 7.20 ´ 10 -6 cm 2 /s), and C is the analyte concentration (C = 5 mM , 2011) . Thus, the porous nature of the VANTA IDEs significantly raises the electroactive surface area above a conventional solid or planar IDE sensor (Laureyn et al., 2001 ) and provides more carbon-carbon defects or active sites than conventional CNT electrodes (Banks et al., 2005 ).
To 
Immunosensing of CIP2A in PBS and saliva
To perform immunosensing of CIP2A (Figure 4) , the VANTA IDEs were functionalized with anti-CIP2A Ab and then incubated with increasing concentrations of CIP2A Ag. EIS measurements revealed that the immunosensor was capable of sensing CIP2A across a wide concentration range from 5 pg/mL to 400 pg/mL in phosphate buffer solution (PBS; see calibration plots in Figure 4a) and from 1-100 pg/ml in saliva supernatant (Figure 4a (Figure 4a,4c,4d) . The linear CIP2A sensing range of the VANTA IDE immunosensor (5-400 pg/ml in PBS and 1-100 pg/ml in saliva) was calculated using regression analysis of the normalized charge transfer resistance versus the functionalized CIP2A concentration plots. The gray shaded area in the plot (Figure 4a) indicates the sensing range of a typical human CIP2A ELISA kit (0.156-10 ng/mL) (Mybiosource, 2013) ; the VANTA IDE sensing platform demonstrates higher sensitivity and a lower sensing range in both PBS and saliva supernatants than the corresponding ELISA. Functionalized VANTA IDEs were also tested in saliva with increased incubation times (30, 45, 60, 90 , and 120 mins) and increased BSA concentrations (0.5%, 1% and 2%), from which the impedance measurements indicated minimal interference/non-specific adsorption from BSA proteins and high stability in the complex saliva matrix (see Figure 4d) . These experiments show that the biofunctionalized VANTA IDEs are relatively resilient to non-specific adsorption of protein and selective to CIP2A with negligible interference from electroactive species found endogenously in saliva supernatant. This implies the feasibility of applying VANTA IDEs toward early stage detection of oral cancers in actual patient saliva samples. 
Statistical analysis and model fitting
To better explain the difference in range of sensing activity between the two sample mediums, the calibration curves for CIP2A detection in saliva and PBS were both fit using nonlinear regression analysis using the Hill Equation (see Figure S1 in Supplemental Information ).
This sigmoidal curve fit indicates the biosensor performance characteristics and enables a better understanding of the binding activity between Ab and Ag within different environments (Akai et al., 2004; Crawford et al., 2012; Rath and Panda, 2015) . The dissociation constant (KD), or Ab affinity to Ag, was calculated for the biosensor operating in both saliva and PBS via the Hill Equation (see Methods). The PBS sensing data resulted in a KD value of 82 pg/ml with a Hill coefficient of 0.98 (or ~ 1 which is indicative of independent binding). However, in saliva the KD value was determined to be 13 pg/ml (higher Ab affinity to Ag than in PBS) with a Hill coefficient of 1.62 (indicative of slight positive cooperative binding). The primary governing factors that control Ab-Ag binding within an aqueous medium are the pH, salt type, temperature, and ionic strength of said medium (Igawa et al., 2010; Zhao et al., 2012) . In the case of this reported VANTA IDE, the decreased KD value or increased antibody affinity to CIP2A Ag and higher level of cooperative binding displayed during biosensing in the saliva supernatant matrix was likely a result of a more optimal pH, salt type, and ionic strength in the saliva solution than in PBS. It is also worth noting that saliva supernatant was used in these experiments so that non-specific absorption from high molecular weight proteins and cellular matter (which could reduce biosensor sensitivity) was minimized as these particles were removed during the centrifugation process (Mohamed et al., 2012) . The biosensor detection limit was estimated from the linear portion of the Hill Equation calibration fit (note the calibration fit includes an initial stationary stage, linear sensing stage, and saturation stage - Figure S1 ). Subsequently the CIP2A detection limit in both PBS and saliva, 4.69 pg/mL and 0.24 pg/ml respectively, were acquired from the intersection between the linear trend line of the Hill Equation calibration fit and the x-axis (using 3 times the standard deviation of the background signal acquired before CIP2A spiking or 3σ guidelines). (Figure 4a, 4c) .
The electrical/electrochemical behavior of the VANTA IDE immunosensor was further evaluated using an equivalent circuit model based on previous reports for IDEs operated in a faradaic EIS sensing modality (i.e., a 2-electrode potentiometric set-up without a reference electrode-the sensing modality used herein for immunosensing) (Ding et al., 2017) . The equivalent circuit model was created for the VANTA IDE biosensors by connecting two constant-phase-elements in parallel with a resister (CPE-R) in series with Rs (i.e., bulk solution ionic resistance according to Randles with the increase of CIP2A concentration. In addition, it proves that the charge transfer resistance was responsible for the detection of CIP2A.
Conclusion
In conclusion, this work demonstrated the first use of VANTA IDEs for electrochemical biosensing of CIP2A. It builds upon the recent body of research that has demonstrated the use of VANTA interdigitated structures for a wide variety of applications including flexible capacitive sensors for wearable strain and force monitoring (Kim et al., 2013) , solid-state micro capacitors (Chiou et al., 2013; Hsia et al., 2014) , and electrostatic torsional actuators (Choi et al., 2012) . The VANTA IDEs developed herein were functionalized with anti-CIP2A Ab and demonstrated a wide linear sensing range between 5 pg/mL and 400 pg/mL, in buffer with a detection limit of 4.69 pg/mL for CIP2A
Ag, a key diagnostic biomarker expressed in saliva during the early stages of oral cancer.
Moreover, the sensor demonstrated the capability of detecting CIP2A in saliva supernatant with a sensing range of 1-100 pg/ml and detection limit of 0.24 pg/ml without the need for sample prelabeling or pre-concentration techniques. This detection limit and sensing range is much lower than the detection range (0.156 ng-10 ng/ml) reported for commercial human CIP2A ELISA kits (Mybiosource, 2013) . Moreover, the total sensing time required for this biosensor is less than 35 minutes (including sample incubation and signal acquisition time). Hence, this work demonstrates great promise in providing a potential platform technology for oral cancer detection at the POC and/or potential for detecting other target analyte in a saliva matrix. Moreover, CIP2A production is also linked to other cancers such as breast and melanoma cancers, and therefore the VANTA (Ohno et al., 2013) . The elimination of 3-electrode patterning and a redox material makes these VANTA-IDEs well-suited for miniaturization, large scale fabrication and potential incorporation into microfluidic channels for multiplex electrochemical sensing of a wide variety of target analytes from a single sample. Moreover, the use of electrochemical devices enables POC sensing as only minimal equipment such as a portable potentiostat (similar to a glucometer)
can be used by non-technical staff to operate the screening tests. Hence electrochemical devices can circumvent the challenges associated with fluorescence/optical based sensors that require complex equipment/processes (e.g., fluorescence microscopes, pre-labeling steps) and that can be impeded by turbid, optically dense or autofluorescent biological samples (Bandodkar et al., 2015) .
Furthermore, the fabrication protocol for 3D CNT electrodes developed herein could be applied to emerging fields that have incorporated CNTs into numerous electrochemical applications including sensors, fuel cells, actuators, and energy harvesters (Hu et al., 2010; Kong and Chen, 2014; Rowe et al., 2011) . 
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